Drugs / Quetiapine XR (extended release)
last change Apr 2012 re-read 3 minutes ago

Quetiapine XR (extended release)

Developed for
major depressive disorder
Investigated by
AstraZeneca · University of Calgary

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02132286 Dec 2008 → Apr 2012 major depressive disorder University of Calgary Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Quetiapine XR (extended release) ClinicalTrials.gov intervention name — accepted as the source's own label NCT02132286 ↗